Stephens & Co. Reiterates Overweight on Steris, Maintains $250 Price Target
Portfolio Pulse from Benzinga Newsdesk
Stephens & Co. analyst Jacob Johnson has reiterated an Overweight rating on Steris (NYSE:STE) and maintained a $250 price target.
September 25, 2023 | 1:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Stephens & Co. has reiterated an Overweight rating on Steris, maintaining a $250 price target.
The reiteration of an Overweight rating by Stephens & Co. indicates their positive outlook on Steris. The maintained price target of $250 suggests they believe the stock is still undervalued. This could potentially lead to an increase in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100